US Patent Issued to ETNOVA THERAPEUTICS on Feb. 17 for "Pharmaceutical composition for oral administration, for treatment of liver cancer" (South Korean Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,468, issued on Feb. 17, was assigned to ETNOVA THERAPEUTICS CORP (Gyeonggi-Do, South Korea).

"Pharmaceutical composition for oral administration, for treatment of liver cancer" was invented by Yong Min Chang (Daegu, South Korea), Sha Joung Chang (Gyeonggi-do, South Korea), Yeoun Hee Kim (Daegu, South Korea) and Md Kamrul Islam (Daegu, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition for oral administration, for treatment of liver cancer, comprising a benzothiazole aniline derivative. The pharmaceutical composition, when orally administered, exhibits a therapeutic effect on liver...